MERCK GLOBAL HEALTH INNOVATION FUND
Merck Global Health Innovation Fund (Merck GHI) is evolving corporate healthcare venture capital globally by utilizing their healthcare ecosystem strategy. This investment strategy connects innovative companies with complementary technologies to develop integrated healthcare solutions. Merck GHI has $500M under management and provides growth capital to emerging healthcare technology companies worldwide while leveraging the vast R&D-based, global resources of Merck. With a vision that data... will be the currency in healthcare, GHI invests broadly in digital health. GHI invests in platform companies with proven technologies or business models where Merck's expertise and perspectives can accelerate revenue growth and enhance value creation. Since late 2010, Merck GHI has made over 20 investments in Digital Health companies.
MERCK GLOBAL HEALTH INNOVATION FUND
Industry:
Finance Health Care Venture Capital
Founded:
2010-01-01
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Content Delivery Network Font Awesome Nginx JsDelivr Cloudflare JS CDN JS OSS CDN Amazon CloudFront
Similar Organizations
Gilde Healthcare
Gilde Healthcare is a healthcare investor that does lower mid-market buyouts and later stage venture.
Tiger Global Management
Tiger Global Management is an investment firm that deploys capital globally in both public and private markets.
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-07-27 | Syapse | Merck Global Health Innovation Fund investment in Venture Round - Syapse | 35 M USD |
| 2022-03-03 | CancerIQ | Merck Global Health Innovation Fund investment in Series B - CancerIQ | 14 M USD |
| 2022-02-07 | Koneksa Health | Merck Global Health Innovation Fund investment in Series C - Koneksa Health | 45 M USD |
| 2022-01-25 | TagNTrac | Merck Global Health Innovation Fund investment in Series A - TagNTrac | 10 M USD |
| 2022-01-14 | Verana Health | Merck Global Health Innovation Fund investment in Series E - Verana Health | 150 M USD |
| 2022-01-11 | PreciseDx | Merck Global Health Innovation Fund investment in Series A - PreciseDx | 10.75 M USD |
| 2022-01-11 | Transcarent | Merck Global Health Innovation Fund investment in Series C - Transcarent | 200 M USD |
| 2021-12-16 | Tasso | Merck Global Health Innovation Fund investment in Series B - Tasso | 100 M USD |
| 2021-12-16 | Verge Genomics | Merck Global Health Innovation Fund investment in Series B - Verge Genomics | 98 M USD |
| 2021-10-11 | Octave Bioscience | Merck Global Health Innovation Fund investment in Venture Round - Octave Bioscience | N/A |
Key Employee Changes
| Date | New article |
|---|---|
| 2021-06-24 | Merck appoints Klobuchar chief strategy officer |